BioMetals, volume 29, issue 3, pages 365-376

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

Rogosnitzky Moshe 1, 2
Branch Stacy 1
Publication typeJournal Article
Publication date2016-04-06
Journal: BioMetals
Quartile SCImago
Q1
Quartile WOS
Q3
Impact factor3.5
ISSN09660844, 15728773
Metals and Alloys
General Biochemistry, Genetics and Molecular Biology
Biomaterials
General Agricultural and Biological Sciences
Abstract
Gadolinium chelates are widely used as contrast media for magnetic resonance imaging. The approved gadolinium-based contrast agents (GBCAs) have historically been considered safe and well tolerated when used at recommended dosing levels. However, for nearly a decade, an association between GBCA administration and the development of nephrogenic systemic fibrosis (NSF) has been recognized in patients with severe renal impairment. This has led to modifications in clinical practices aimed at reducing the potential and incidence of NSF development. Newer reports have emerged regarding the accumulation of gadolinium in various tissues of patients who do not have renal impairment, including bone, brain, and kidneys. Despite the observations of gadolinium accumulation in tissues regardless of renal function, very limited clinical data regarding the potential for and mechanisms of toxicity is available. This significant gap in knowledge warrants retrospective cohort study efforts, as well as prospective studies that involve gadolinium ion (Gd3+) testing in patients exposed to GBCA. This review examines the potential biochemical and molecular basis of gadolinium toxicity, possible clinical significance of gadolinium tissue retention and accumulation, and methods that can limit gadolinium body burden.

Citations by journals

2
4
6
8
10
Scientific Reports
Scientific Reports, 10, 1.91%
Scientific Reports
10 publications, 1.91%
Radiology
Radiology, 9, 1.72%
Radiology
9 publications, 1.72%
Molecules
Molecules, 9, 1.72%
Molecules
9 publications, 1.72%
Nanomaterials
Nanomaterials, 9, 1.72%
Nanomaterials
9 publications, 1.72%
Journal of Magnetic Resonance Imaging
Journal of Magnetic Resonance Imaging, 8, 1.53%
Journal of Magnetic Resonance Imaging
8 publications, 1.53%
Journal of Materials Chemistry B
Journal of Materials Chemistry B, 8, 1.53%
Journal of Materials Chemistry B
8 publications, 1.53%
Investigative Radiology
Investigative Radiology, 7, 1.34%
Investigative Radiology
7 publications, 1.34%
ACS applied materials & interfaces
ACS applied materials & interfaces, 7, 1.34%
ACS applied materials & interfaces
7 publications, 1.34%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 6, 1.15%
International Journal of Molecular Sciences
6 publications, 1.15%
Nanoscale
Nanoscale, 6, 1.15%
Nanoscale
6 publications, 1.15%
Pharmaceutics
Pharmaceutics, 5, 0.95%
Pharmaceutics
5 publications, 0.95%
Nanotechnology
Nanotechnology, 5, 0.95%
Nanotechnology
5 publications, 0.95%
Magnetic Resonance Imaging
Magnetic Resonance Imaging, 5, 0.95%
Magnetic Resonance Imaging
5 publications, 0.95%
International Journal of Nanomedicine
International Journal of Nanomedicine, 5, 0.95%
International Journal of Nanomedicine
5 publications, 0.95%
ACS Applied Bio Materials
ACS Applied Bio Materials, 4, 0.76%
ACS Applied Bio Materials
4 publications, 0.76%
Biomolecules
Biomolecules, 4, 0.76%
Biomolecules
4 publications, 0.76%
Biomaterials
Biomaterials, 4, 0.76%
Biomaterials
4 publications, 0.76%
Journal of Trace Elements in Medicine and Biology
Journal of Trace Elements in Medicine and Biology, 4, 0.76%
Journal of Trace Elements in Medicine and Biology
4 publications, 0.76%
Science of the Total Environment
Science of the Total Environment, 4, 0.76%
Science of the Total Environment
4 publications, 0.76%
Coordination Chemistry Reviews
Coordination Chemistry Reviews, 4, 0.76%
Coordination Chemistry Reviews
4 publications, 0.76%
Advanced healthcare materials
Advanced healthcare materials, 4, 0.76%
Advanced healthcare materials
4 publications, 0.76%
ACS Omega
ACS Omega, 4, 0.76%
ACS Omega
4 publications, 0.76%
ACS Applied Nano Materials
ACS Applied Nano Materials, 4, 0.76%
ACS Applied Nano Materials
4 publications, 0.76%
Journal of Controlled Release
Journal of Controlled Release, 3, 0.57%
Journal of Controlled Release
3 publications, 0.57%
Korean Journal of Radiology
Korean Journal of Radiology, 3, 0.57%
Korean Journal of Radiology
3 publications, 0.57%
Pharmaceuticals
Pharmaceuticals, 3, 0.57%
Pharmaceuticals
3 publications, 0.57%
Frontiers in Oncology
Frontiers in Oncology, 3, 0.57%
Frontiers in Oncology
3 publications, 0.57%
Pediatric Radiology
Pediatric Radiology, 3, 0.57%
Pediatric Radiology
3 publications, 0.57%
Skeletal Radiology
Skeletal Radiology, 3, 0.57%
Skeletal Radiology
3 publications, 0.57%
2
4
6
8
10

Citations by publishers

20
40
60
80
100
120
Elsevier
Elsevier, 112, 21.37%
Elsevier
112 publications, 21.37%
Springer Nature
Springer Nature, 68, 12.98%
Springer Nature
68 publications, 12.98%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 56, 10.69%
Multidisciplinary Digital Publishing Institute (MDPI)
56 publications, 10.69%
Wiley
Wiley, 55, 10.5%
Wiley
55 publications, 10.5%
American Chemical Society (ACS)
American Chemical Society (ACS), 40, 7.63%
American Chemical Society (ACS)
40 publications, 7.63%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 31, 5.92%
Royal Society of Chemistry (RSC)
31 publications, 5.92%
Wolters Kluwer Health
Wolters Kluwer Health, 14, 2.67%
Wolters Kluwer Health
14 publications, 2.67%
Frontiers Media S.A.
Frontiers Media S.A., 12, 2.29%
Frontiers Media S.A.
12 publications, 2.29%
IOP Publishing
IOP Publishing, 11, 2.1%
IOP Publishing
11 publications, 2.1%
Radiological Society of North America (RSNA)
Radiological Society of North America (RSNA), 9, 1.72%
Radiological Society of North America (RSNA)
9 publications, 1.72%
Taylor & Francis
Taylor & Francis, 6, 1.15%
Taylor & Francis
6 publications, 1.15%
Oxford University Press
Oxford University Press, 6, 1.15%
Oxford University Press
6 publications, 1.15%
Dove Medical Press
Dove Medical Press, 5, 0.95%
Dove Medical Press
5 publications, 0.95%
American Institute of Physics (AIP)
American Institute of Physics (AIP), 4, 0.76%
American Institute of Physics (AIP)
4 publications, 0.76%
Bentham Science
Bentham Science, 4, 0.76%
Bentham Science
4 publications, 0.76%
Hindawi Limited
Hindawi Limited, 4, 0.76%
Hindawi Limited
4 publications, 0.76%
American Association for the Advancement of Science (AAAS)
American Association for the Advancement of Science (AAAS), 3, 0.57%
American Association for the Advancement of Science (AAAS)
3 publications, 0.57%
The Korean Society of Radiology
The Korean Society of Radiology, 3, 0.57%
The Korean Society of Radiology
3 publications, 0.57%
Pleiades Publishing
Pleiades Publishing, 3, 0.57%
Pleiades Publishing
3 publications, 0.57%
American Society of Neuoradiology, 3, 0.57%
American Society of Neuoradiology
3 publications, 0.57%
Radiation Research Society, 3, 0.57%
Radiation Research Society
3 publications, 0.57%
The Royal Society
The Royal Society, 2, 0.38%
The Royal Society
2 publications, 0.38%
The Company of Biologists
The Company of Biologists, 2, 0.38%
The Company of Biologists
2 publications, 0.38%
Future Medicine
Future Medicine, 2, 0.38%
Future Medicine
2 publications, 0.38%
American Roentgen Ray Society
American Roentgen Ray Society, 2, 0.38%
American Roentgen Ray Society
2 publications, 0.38%
SAGE
SAGE, 2, 0.38%
SAGE
2 publications, 0.38%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 2, 0.38%
Public Library of Science (PLoS)
2 publications, 0.38%
Society for the Study of Reproduction
Society for the Study of Reproduction, 2, 0.38%
Society for the Study of Reproduction
2 publications, 0.38%
Walter de Gruyter
Walter de Gruyter, 2, 0.38%
Walter de Gruyter
2 publications, 0.38%
20
40
60
80
100
120
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Rogosnitzky M., Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms // BioMetals. 2016. Vol. 29. No. 3. pp. 365-376.
GOST all authors (up to 50) Copy
Rogosnitzky M., Branch S. Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms // BioMetals. 2016. Vol. 29. No. 3. pp. 365-376.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s10534-016-9931-7
UR - https://doi.org/10.1007%2Fs10534-016-9931-7
TI - Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
T2 - BioMetals
AU - Rogosnitzky, Moshe
AU - Branch, Stacy
PY - 2016
DA - 2016/04/06 00:00:00
PB - Springer Nature
SP - 365-376
IS - 3
VL - 29
PMID - 27053146
SN - 0966-0844
SN - 1572-8773
ER -
BibTex |
Cite this
BibTex Copy
@article{2016_Rogosnitzky
author = {Moshe Rogosnitzky and Stacy Branch},
title = {Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms},
journal = {BioMetals},
year = {2016},
volume = {29},
publisher = {Springer Nature},
month = {apr},
url = {https://doi.org/10.1007%2Fs10534-016-9931-7},
number = {3},
pages = {365--376},
doi = {10.1007/s10534-016-9931-7}
}
MLA
Cite this
MLA Copy
Rogosnitzky, Moshe, et al. “Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms.” BioMetals, vol. 29, no. 3, Apr. 2016, pp. 365-376. https://doi.org/10.1007%2Fs10534-016-9931-7.
Found error?